Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Eze Castle expands private cloud services to Hong Kong and Singapore

Wednesday, November 14, 2012
Opalesque Industry Update - Eze Castle Integration, a provider of strategic IT solutions and private cloud services to hedge funds, announced it has expanded its Eze Private Cloud services to Hong Kong and Singapore. With this expansion, the hedge fund industry’s preferred private cloud now spans three continents and provides firms seamless access to the technology and key applications required to operate effectively and efficiently.

The Eze Private Cloud is used by more than 2,000 hedge fund professionals worldwide to simplify operations, minimize upfront capital costs and gain a highly resilient, enterprise-grade IT infrastructure on par with billion-dollar funds. Hedge funds based in Hong Kong and Singapore now have access to a range of offerings from the Eze Private Cloud, including the Eze Managed Suite and application hosting. The Eze Managed Suite is a hosted IT solution providing firms with a fully managed infrastructure and key business applications. The Eze Managed Suite gives users file services, email, software applications, mobile services, email security, disaster recovery and 24x7x365 support.

“Eze Castle Integration sees tremendous opportunity for private cloud services in the Asia Pacific region as hedge funds around the world embrace the cloud to streamline and enhance their operations,” said Serge Bukhar, executive director of international operations, Eze Castle Integration. “This latest expansion of the Eze Private Cloud reinforces our commitment to being the global technology partner to the hedge fund industry and fills a market need for fully managed cloud services that combine premier technology with exceptional client support.”

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for